$22.61
-0.640 (-2.75%)
At Close: Jun 03, 2026
Chemours (CC) Outpaces Stock Market Gains: What You Should Know
09:45pm, Tuesday, 29'th Mar 2022 Zacks Investment Research
Chemours (CC) closed the most recent trading day at $32.18, moving +1.71% from the previous trading session.
Chemours (CC) is a Top-Ranked Value Stock: Should You Buy?
02:00pm, Friday, 25'th Mar 2022 Zacks Investment Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Chemours (CC) Gains As Market Dips: What You Should Know
09:45pm, Wednesday, 23'rd Mar 2022 Zacks Investment Research
Chemours (CC) closed at $30.55 in the latest trading session, marking a +0.03% move from the prior day.
Chemours (CC) Gains But Lags Market: What You Should Know
09:45pm, Thursday, 17'th Mar 2022 Zacks Investment Research
Chemours (CC) closed the most recent trading day at $29.17, moving +1.14% from the previous trading session.
Chemours (CC) Gains But Lags Market: What You Should Know
06:48pm, Thursday, 17'th Mar 2022
Chemours (CC) closed the most recent trading day at $29.17, moving +1.14% from the previous trading session.
Chemours (CC) Gains As Market Dips: What You Should Know
10:45pm, Thursday, 10'th Mar 2022 Zacks Investment Research
In the latest trading session, Chemours (CC) closed at $25.88, marking a +1.61% move from the previous day.
Chemours (CC) is a Top-Ranked Growth Stock: Should You Buy?
03:00pm, Thursday, 10'th Mar 2022 Zacks Investment Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Chemours Company (The) – Consensus Indicates Potential 61.8% Upside
12:12pm, Tuesday, 08'th Mar 2022 DirectorsTalk
Chemours Company (The) with ticker code (CC) have now 11 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 53 and 34 with a mean TP of 40.82. Given that the stocks previous close was at 25.23 this now indicates there is a potential upside of 61.8%. There is a 50 day moving average of 32.37 and the 200 day moving average is 32.42. The company has a market capitalisation of $3,700m. You can visit the company''s website by visiting: https://www.chemours.com [stock_market_widget type="chart" template="basic" color="green" assets=CC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $5,986m based on the market concensus. The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions.
3 Wildly Undervalued Dividend Stocks to Buy in March
11:00am, Sunday, 06'th Mar 2022 The Motley Fool
Boost your passive income stream from three companies you can count on.
3 Wildly Undervalued Dividend Stocks to Buy in March
06:00am, Sunday, 06'th Mar 2022
Boost your passive income stream from three companies you can count on.
17 Fair Priced 2022 Best Bet Dividends Beckon In March
03:50am, Thursday, 03'rd Mar 2022
Back in November-December 2021, Kiplinger and Barron's reporters combined to list ten sets of stocks sorted as best-bets for 2022. Those ten "Best-Bets" articles revealed 123 equities, with 88 paying
Chemours Company (The) – Consensus Indicates Potential 43.5% Upside
11:10am, Tuesday, 01'st Mar 2022 DirectorsTalk
Chemours Company (The) found using ticker (CC) now have 11 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 53 and 34 with the average target price sitting at 41.18. Given that the stocks previous close was at 28.69 this would imply there is a potential upside of 43.5%. The 50 day MA is 32.94 and the 200 moving average now moves to 32.61. The market capitalisation for the company is $4,416m. Company Website: https://www.chemours.com [stock_market_widget type="chart" template="basic" color="green" assets=CC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $6,339m based on the market concensus. The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
Tracking David Einhorn's Greenlight Capital Portfolio - Q4 2021 Update
05:33am, Monday, 28'th Feb 2022 Seeking Alpha
David Einhorn's GLRE 13F stock portfolio value increased from $1.49B to $1.75B this quarter. The largest 3 positions are at ~48% of the portfolio.
Chemours must face shareholder lawsuit over ''forever chemicals''
08:22pm, Thursday, 24'th Feb 2022 Reuters
A U.S. judge on Thursday ruled that Chemours Co must face shareholders'' claim that it understated the maximum costs associated with cleaning up certain long-lived chemicals after the company was spun off from E.I. du Pont de Nemours and Co.
Sign In
Buy CC